Literature DB >> 9191437

Rectal tumours--MR imaging with endorectal and/or phased-array coils, and histopathological staging on giant sections. A comparative study.

L Blomqvist1, T Holm, C Rubio, T Hindmarsh.   

Abstract

OBJECTIVE: To investigate the accuracy of MR imaging in the preoperative staging of patients with clinically resectable rectal tumours.
MATERIAL AND METHODS: Forty-eight consecutive patients with rectal tumours were examined, 29 with a pelvic phased-array coil and 19 with a multi-coil arrangement including a pelvic phased-array coil and an endorectal coil. MR images and histopathological specimens and sections were reviewed independently and tumours were staged according to the TNM classification.
RESULTS: A more complete visualisation of the various layers of the rectal wall was achieved on the endorectal MR images than on the pelvic phased-array images. The sensitivity of MR in correctly staging T3 tumours compared with histopathology was 81% with a specificity of 82%. Penetration of the rectal wall was predicted with a sensitivity of 82% and a specificity of 87%. Sensitivity and specificity in predicting lymph node metastases was 83% and 74% respectively.
CONCLUSION: MR imaging with both pelvic phased-array and endorectal coils allowed the preoperative staging of rectal tumours with a high degree of accuracy.

Entities:  

Mesh:

Year:  1997        PMID: 9191437     DOI: 10.1080/02841859709172097

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  14 in total

Review 1.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization.

Authors:  Hale Çolakoğlu Er; Elif Peker; Ayşe Erden; İlhan Erden; Ethem Geçim; Berna Savaş
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

3.  Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia.

Authors:  Michael R Torkzad; Karl A Hansson; Johan Lindholm; Anna Martling; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2006-12-21       Impact factor: 5.315

4.  MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry.

Authors:  Michael R Torkzad; Johan Lindholm; Anna Martling; Björn Cedermark; Bengt Glimelius; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2007-01-31       Impact factor: 5.315

5.  Role of tumor size in the pre-operative management of rectal cancer patients.

Authors:  Inti Zlobec; Parham Minoo; Eva Karamitopoulou; George Peros; Efstratios S Patsouris; Frank Lehmann; Alessandro Lugli
Journal:  BMC Gastroenterol       Date:  2010-06-15       Impact factor: 3.067

6.  Retrospective measurement of different size parameters of non-radiated rectal cancer on MR images and pathology slides and their comparison.

Authors:  Michael Torkzad; Johan Lindholm; Anna Martling; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2003-05-10       Impact factor: 5.315

Review 7.  MRI in local staging of rectal cancer: an update.

Authors:  Umit Tapan; Mustafa Ozbayrak; Servet Tatlı
Journal:  Diagn Interv Radiol       Date:  2014 Sep-Oct       Impact factor: 2.630

Review 8.  Transanal endoscopic microsurgery: a review.

Authors:  Behrouz Heidary; Terry P Phang; Manoj J Raval; Carl J Brown
Journal:  Can J Surg       Date:  2014-04       Impact factor: 2.089

Review 9.  Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin?

Authors:  R G H Beets-Tan; G L Beets
Journal:  Int J Colorectal Dis       Date:  2003-03-07       Impact factor: 2.571

10.  Preoperative rectal cancer staging with phased-array MR.

Authors:  Sabina Giusti; Piero Buccianti; Maura Castagna; Elena Fruzzetti; Silvia Fattori; Elisa Castelluccio; Davide Caramella; Carlo Bartolozzi
Journal:  Radiat Oncol       Date:  2012-03-05       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.